醫療保健板塊因製藥公司業績表現不一而下跌——醫療保健綜述

醫療保健股票在主要製藥公司發佈混合財報後下跌。輝瑞的股票因癌症和心臟病藥物銷售強勁，抵消了 COVID-19 產品的下滑，儘管超出了盈利目標，股價上漲。默克的股票略微上漲，因為它因 Terns Pharmaceuticals 收購的單次費用下調了年度利潤預測。相反，儘管諾和諾德提高了年度收入預測，其股票仍然下滑

Health-care companies ticked down after mixed earnings from Big Pharma companies. Investors rotated out of defensive areas into cyclical stocks.

Pfizer shares rose after the New York drug giant posted second-quarter earnings above Wall Street targets, as rising sales of drugs for cancer and heart disease helped offset steep declines for Covid-19 products.

Merck slashed its profit projection for the year, citing one-off charges tied to its acquisition of cancer biotech company Terns Pharmaceuticals. Shares of Merck rose slightly.

Shares of Danish obesity-drug maker Novo Nordisk slid despite raising its revenue projection for the year.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

August 04, 2026 18:12 ET (22:12 GMT)